Compugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific Conferences

Provided By PR Newswire

Last update: Jun 12, 2025

HOLON, Israel, June 12, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the presentation of AI/ML driven predictive computational research at upcoming international scientific conferences reflecting Compugen's scientific capabilities in understanding complex cancer biology.